3 completed. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 3 | 1 | Completed 1 |
Follow Progression Free Survival: new trials by email Literature Review of Progression Free Survival trials Research Report on Progression Free Survival
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Maintenance Therapy for Small-cell Lung Cancer cis Platinum, etoposide, S1 - Progression Free Survival | Phase 2 | Completed | Qingdao Central Hospital | 90 | 2017-01-01 | 2023-03-29 |
| Osimertinib or Docetaxel-bevacizumab as Third-line Treatment in EGFR T790M Mutated Non-Small Cell Lung Cancer Osimertinib, docetaxel, bevacizumab - Progression Free Survival | Phase 2 / Phase 3 | Completed | Qingdao Central Hospital | 147 | 2015-08-01 | 2018-02-14 |
| Study of Target-Guided Chemotherapy in Metastatic Colorectal Patients Tailored Chemotherapy - Progression Free Survival | Phase 2 | Completed | Grupo Hospital de Madrid | 72 | 2009-10-01 | 2011-10-19 |
Colonic Diseases (1) · Colorectal Neoplasms (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Intestinal Diseases (1) · Intestinal Neoplasms (1) · Neoplasms (1) · Neoplasms by Site (1)
Bevacizumab (1) · Cisplatin (1) · Docetaxel (1) · Etoposide (1) · S 1 (combination) (1) · osimertinib (1)
Qingdao Central Hospital (2) · Grupo Hospital de Madrid (1)
China (2) · Spain (1)